Khoynezhad Ali, Toluie Sherwin, Al-Atassi Talal
Division of Cardiothoracic Surgery, Cedars-Sinai Medical Center, Los Angeles, California.
Division of Cardiothoracic Surgery, Cedars-Sinai Medical Center, Los Angeles, California.
Semin Thorac Cardiovasc Surg. 2017;29(2):131-136. doi: 10.1053/j.semtcvs.2017.03.001. Epub 2017 Mar 21.
Although thoracic endovascular aortic repair (TEVAR) is the standard of care in acute complicated type B dissections, its role in chronic type B dissections remains controversial. This controversy stems from anatomical differences between acute and chronic dissections, such as a thicker intimal clap and improved results in descending aortic replacement. However, despite these important differences, there has been accumulating evidence on the safety and efficacy of TEVAR in chronic type B aortic dissections, especially when considering the alternative of open surgical repair, which is associated with significantly higher morbidity and in many hands also higher mortality. Herein, we discuss the evidence in the literature highlighting TEVAR's safety and efficacy in this setting.
尽管胸主动脉腔内修复术(TEVAR)是急性复杂性B型夹层的标准治疗方法,但其在慢性B型夹层中的作用仍存在争议。这种争议源于急性和慢性夹层之间的解剖学差异,如内膜瓣增厚以及降主动脉置换术效果改善。然而,尽管存在这些重要差异,但越来越多的证据表明TEVAR在慢性B型主动脉夹层中具有安全性和有效性,特别是考虑到开放手术修复这种替代方法,其并发症发生率显著更高,而且在许多情况下死亡率也更高。在此,我们讨论文献中的证据,突出TEVAR在这种情况下的安全性和有效性。